Join
Live feed
·
PRReleasevia Quantisnow
ADC Therapeutics SA logo
The Carlyle Group Inc. logo

Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development

ByQuantisnow·Wall Street's wire, on your screen.
ADCT· ADC Therapeutics SACG· The Carlyle Group Inc.
Health CareFinance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADCT (ADC Therapeutics SA), CG (The Carlyle Group Inc.) and more on Quantisnow.